Filing Details
- Accession Number:
- 0001127602-15-004456
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2015-02-05 11:40:41
- Reporting Period:
- 2015-02-03
- Filing Date:
- 2015-02-05
- Accepted Time:
- 2015-02-05 11:40:41
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
799729 | Parexel International Corp | PRXL | Services-Commercial Physical & Biological Research (8731) | 042776269 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1552687 | Gadi Saarony | C/O Parexel International 195 West Street Waltham MA 02451 | Corp. Sr. Vp, Crs | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2015-02-03 | 6,200 | $20.26 | 17,300 | No | 4 | M | Direct | |
Common Stock | Acquisiton | 2015-02-03 | 2,325 | $30.64 | 19,625 | No | 4 | M | Direct | |
Common Stock | Disposition | 2015-02-03 | 8,525 | $60.97 | 11,100 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Stock Option (Right to Buy) | Disposition | 2015-02-03 | 6,200 | $0.00 | 6,200 | $20.26 |
Common Stock | Stock Option (Right to Buy) | Disposition | 2015-02-03 | 2,325 | $0.00 | 2,325 | $30.64 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
6,200 | 2019-09-21 | No | 4 | M | Direct | |
4,650 | 2020-09-19 | No | 4 | M | Direct |
Footnotes
- This transaction was executed in multiple trades through a trade order executed by a broker-dealer at prices ranging from $60.96- $61.04. The price reported in this column reflects the weighted average sale price. For all transactions reported on this Form 4 utilizing a weighted average sale price, the reporting person will provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares sold at each price.
- Options become exercisable in increments of 25% of the total shares granted commencing on the first anniversary of the date of grant.